These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32802325)

  • 1. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review.
    Napoli C; Tritto I; Benincasa G; Mansueto G; Ambrosio G
    Ann Med Surg (Lond); 2020 Sep; 57():236-243. PubMed ID: 32802325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of COVID-19 on the Cardiovascular System.
    Aras Júnior R; Durães A; Roever L; Macedo C; Aras MG; Nascimento L; Improta-Caria AC; De Sousa RAL; Mansueto GN
    Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):163-167. PubMed ID: 34259776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
    Chatterjee SK; Saha S; Munoz MNM
    Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
    Valencia I; Peiró C; Lorenzo Ó; Sánchez-Ferrer CF; Eckel J; Romacho T
    Front Pharmacol; 2020; 11():1161. PubMed ID: 32848769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review.
    Mascolo A; Scavone C; Rafaniello C; Ferrajolo C; Racagni G; Berrino L; Paolisso G; Rossi F; Capuano A
    Front Cardiovasc Med; 2020; 7():143. PubMed ID: 32850989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report on transient cardiomyopathy with cytokine storm in SARS-CoV-2.
    Tarun T; Kumar S; Johnson J; Chockalingam A
    Eur Heart J Case Rep; 2021 Feb; 5(2):ytaa519. PubMed ID: 33594344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta receptor blocker therapy for the elderly in the COVID-19 era.
    Santillo E; Migale M
    World J Clin Cases; 2022 Aug; 10(23):8088-8096. PubMed ID: 36159512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: A Comprehensive Review on Cardiovascular Alterations, Immunity, and Therapeutics in Older Adults.
    Rivera-Torres J; Girón N; San José E
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people.
    Colombo C; Garatti L; Ferrante G; Casadei F; Montalto C; Crimi G; Cogliati C; Ammirati E; Savonitto S; Morici N
    J Geriatr Cardiol; 2021 Jul; 18(7):534-548. PubMed ID: 34404990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19, cardiac involvement and cardiac rehabilitation: Insights from a rehabilitation perspective - State of the Art.
    Sonel Tur B; Köseoğlu BF; Kutay Ordu Gökkaya N; Kurtaiş Aytür Y; Özyemişci Taşkıran Ö; Demirbağ Kabayel D; Kesiktaş N; Tıkız C; Özdemir H; Alemdaroğlu E; Bilir Kaya B; Genç A; Tomruk Sütbeyaz S
    Turk J Phys Med Rehabil; 2022 Sep; 68(3):317-335. PubMed ID: 36475104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Nicotine Prevent Cytokine Storms in COVID-19?
    Dratcu L; Boland X
    Cureus; 2020 Oct; 12(10):e11220. PubMed ID: 33269148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential association between immunosenescence and high COVID-19 related mortality among elderly patients with cardiovascular diseases.
    Wang Y; Pang SC; Yang Y
    Immun Ageing; 2021 Jun; 18(1):25. PubMed ID: 34074305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Cardiovascular Disease in Patients With COVID-19 and Chronic Chagas Disease: Implications to Prevent a Scourge Still Larger.
    Bestetti RB; Bocchi EA; Bestetti R; Issa VS; Furlan-Daniel RA; Nakazone MA
    Front Med (Lausanne); 2022; 9():910388. PubMed ID: 35847824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Disease Risk and Outcomes in Patients Infected With SARS-CoV-2.
    Espinoza D; Jasti M; Malwi UH; Junia C
    Cureus; 2021 Jan; 13(1):e12783. PubMed ID: 33628655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence-based debate on epigenetics and immunosenescence in COVID-19.
    Napoli C; Coscioni E; Trama U; Strozziero MG; Benincasa G
    Curr Res Immunol; 2023; 4():100069. PubMed ID: 37781451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients.
    Yang F; Yue R; Luo X; Liu R; Huang X
    Front Pharmacol; 2020; 11():543718. PubMed ID: 33178011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why the complications of COVID-19 patients differ in elderly and young cancer patients.
    Bravaccini S; Nicolini F; Zanoni M; Gaimari A; Cerchione C; Maltoni R; Pirini F; Mazzotti L; Cortesi M; Ravaioli S; Tumedei MM; Mazza M
    Transl Oncol; 2022 Dec; 26():101541. PubMed ID: 36119944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics and Severity of COVID-19 Disease in Patients from Boston Area Hospitals.
    Dashti HT; Bates D; Fiskio JM; Roche EC; Mora S; Demler O
    medRxiv; 2020 Aug; ():. PubMed ID: 32793930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System.
    Alqahtani MS; Abbas M; Alsabaani A; Alqarni A; Almohiy HM; Alsawqaee E; Alshahrani R; Alshahrani S
    Infect Drug Resist; 2022; 15():1175-1189. PubMed ID: 35345472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac drug therapy-considerations in the elderly.
    Ayan M; Pothineni NV; Siraj A; Mehta JL
    J Geriatr Cardiol; 2016 Dec; 13(12):992-997. PubMed ID: 28321243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.